Corporate

Corporate

Biotrial introduces its entity BIOTRIAL ONCOLOGY

For over 35 years, Biotrial has been an innovative player in the field, both in Preclinical and Clinical studies. In response to evolving needs, Biotrial has decided to launch its…

Read more

Corporate

The Journey of Séverine Le Helloco

Empowering Women in the World of Science…

Read more

Corporate

Biotrial 2023 annual newsletter

From breakthrough MESHCAP project advancements to our commitment to growth through the Boost 2030 plan, Biotrial’s 2023 was a testament to excellence and innovation. Download the 2023 newsletter…

Read more

Corporate

Expert Interview: Medical Writing (Video + Transcript)

The Essential Link in the Drug Development Chain Medical writers play a critical role in the drug development process. They work with scientists, clinicians, and regulatory experts to produce clear…

Read more

Corporate

Introducing François Peaucelle as Biotrial’s New CEO

Biotrial would like to announce the start of an exciting new chapter for our organization with François Peaucelle as our new CEO. François is well-positioned to lead Biotrial into the…

Read more

Corporate

Highlights from Biotrial’s Open House

Biotrial recently hosted an Open House event at our state-of-the-art facilities in Rennes, France, focusing on the success factors in Clinical Research. We want to share the key highlights of…

Read more

Corporate

A TRIBUTE TO BIOTRIAL’S FOUNDER: Jean-Marc Gandon

May 2023, Biotrial shared the sad news of the passing of its President, CEO, and founder, Jean-Marc Gandon after a courageous battle against cancer. It is an irreplaceable loss for…

Read more

Corporate

Biotrial’s Team Meets with the students in Statistics and Business Intelligence at the IUT de Vannes.

Our HR team had the pleasure of meeting with students to discuss potential career opportunities in Statistics and Business Intelligence with Biotrial...

Read more

Corporate

Biotrial and IGDR Join forces to Develop Innovative Anticancer Drugs

Biotrial and the IGDR (Institute of Genetics and Development of Rennes) research team have recently been awarded funding from “France Relance” to work on a joint R&D project in comparative…

Read more